HPV Vaccination Program Launched in Andhra Pradesh
On Saturday, Chief Minister N. Chandrababu Naidu inaugurated a free Human Papillomavirus (HPV) vaccination initiative aimed at approximately 3.45 lakh girls in Andhra Pradesh. This vaccine seeks to combat cervical cancer and is targeted at girls aged 14 in the state. It’s important to note that while the vaccine can help prevent the onset of cancer, it won’t treat any existing HPV infections or cancers.
The launch took place in Cheepurupalli, Vizianagaram district, and coincided with a nationwide rollout by Prime Minister Narendra Modi in Ajmer, Rajasthan. Depending on demand, the central government will provide additional doses as necessary.
Before vaccination, parental consent will be required. Following the procedure, recipients will be monitored for about thirty minutes to ensure there are no immediate adverse reactions.
This vaccination effort comes in response to troubling cancer statistics in the state. Between 2021 and 2025, Andhra Pradesh has recorded around 75,000 new cancer cases each year, resulting in approximately 30,000 deaths annually. Among the women who died from breast, cervical, and ovarian cancers during this time, 53% were due to breast cancer and 31% from cervical cancer. The HPV vaccine, delivered in a 0.5 ml dose, provides protection against four key virus strains (types 6, 11, 16, and 18) known to cause cervical cancer.
The HPV vaccine is recognized as a highly effective and safe non-live vaccine that prevents infections associated with cervical, vaginal, and anal cancers. Health professionals strongly recommend administering it to young adolescents, particularly to girls ages 9 to 14, before they become sexually active. Since HPV is a highly contagious virus typically spread through sexual contact, getting vaccinated before exposure is considered optimal.
Previously, the vaccine required two or three doses, but there’s now a shift towards a single-dose approach for young girls. The vaccine has been thoroughly researched, with over 500 million doses administered worldwide. Mild side effects, such as slight pain or redness at the injection site, may occur after vaccination.
Research has indicated that younger adolescents tend to generate a stronger immune response to the HPV vaccine compared to older individuals. It’s also noted that vaccinating boys or women over 18 usually requires more doses to achieve similar cancer prevention results, making it less cost-effective.
